[Supportive therapy for myelodysplastic syndrome (MDS). Indispensable pillar in the multimodal treatment concept].
Göbel
Alexandra
A
Apotheke des Universitätsklinikums Freiburg, Hugstetter Strasse 55, 79106 Freiburg. alexandra.goebel@uniklinik-freiburg.de
Lubrich
Beate
B
D000890:Anti-Infective Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D017707:Erythrocyte Transfusion; D006801:Humans; D007116:Immunization, Passive; D007155:Immunologic Factors / Q000627:therapeutic use; D007502:Iron Chelating Agents / Q000627:therapeutic use; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000628:therapy*; D017713:Platelet Transfusion; D011961:Receptors, Fc / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D013926:Thrombopoietin / Q000627:therapeutic use
D000890:Anti-Infective Agents; D007155:Immunologic Factors; D007502:Iron Chelating Agents; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim